Certified by Founder
Lodge
Myrobalan Therapeutics
start up
United States
- Medford, Massachusetts
- 11/01/2024
- Series A
- $24,000,000
Developing therapeutics to address the unmet need and societal burdens posed by neurodegenerative, demyelinating and neuropsychiatric disorders.
- Industry Biotechnology Research
- Website https://myrotx.com/
- LinkedIn https://www.linkedin.com/company/myrobalantx/about/
Datatruck | $12,000,000 | (Jan 29, 2026)
Vention | $110,000,000 | (Jan 29, 2026)
Tenbin Labs | $7,000,000 | (Jan 29, 2026)
Oro(US) | $3,000,000 | (Jan 29, 2026)
Yolando | $8,500,000 | (Jan 29, 2026)
Origin(US) | Undisclosed Amount | (Jan 29, 2026)
Gyde | $60,000,000 | (Jan 29, 2026)
Limy AI | $10,000,000 | (Jan 29, 2026)
Scholé AI | $3,000,000 | (Jan 29, 2026)
Emobi | $3,400,000 | (Jan 29, 2026)
Adaptive6 | $28,000,000 | (Jan 29, 2026)
Fiddler AI | $30,000,000 | (Jan 28, 2026)